In this preliminary work, we found differences in TSC2 and PMS2 mutation frequency and PI3K oncogenic pathway activation in a cohort of 40 CRC from Chilean patients compared to other cohorts. The gene discussed is PIK3CA; the disease is colorectal carcinoma.